StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report issued on Wednesday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Trading Up 2.3 %
Shares of CPIX stock opened at $1.31 on Wednesday. The firm has a market capitalization of $18.59 million, a P/E ratio of -2.22 and a beta of 0.20. Cumberland Pharmaceuticals has a 1 year low of $1.20 and a 1 year high of $2.36. The firm’s fifty day simple moving average is $1.32 and its 200 day simple moving average is $1.47. The company has a current ratio of 1.44, a quick ratio of 1.26 and a debt-to-equity ratio of 0.62.
Cumberland Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Cumberland Pharmaceuticals
- What Are Dividend Champions? How to Invest in the Champions
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Investing in the High PE Growth Stocks
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- What is the NASDAQ Stock Exchange?
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.